Talis Biomedical Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Talis Biomedical Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • Talis Biomedical Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $7.91M, a 50.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.91M -$8.12M -50.7% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $8.15M -$4.14M -33.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $12.4M -$18.5M -59.8% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $12.8M -$22.3M -63.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $16M -$19.8M -55.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $12.3M -$404K -3.18% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $30.9M +$18M +140% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $35.1M +$21.7M +162% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $35.8M +$22M +160% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $12.7M +$12.3M +3073% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $12.9M +$12.3M +2176% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $13.4M Sep 30, 2021 10-Q 2021-11-16
Q2 2021 $13.7M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $400K Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $567K Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.